Both in Pharmaceuticals
BioVie vs Phio Pharmaceuticals
Over the past year BIVI returned −19.9% and PHIO returned −52.7%; their daily moves had a correlation of 0.20.
BIVI −19.9% PHIO −52.7%Growth of $1, one year, split-adjusted
| Metric | BIVI | PHIO |
|---|---|---|
| Price | $1.37 | $0.8800 |
| Market cap | $11.9M | $10.2M |
| Today | −4.20% | +2.33% |
| 1 month | −6.2% | −10.7% |
| 6 months | −20.3% | −24.1% |
| Year to date | +18.1% | −16.2% |
| 1 year | −22.6% | −57.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.0M | $13.0M |
| Dividend yield | — | — |
| Volatility (60d) | 148.0% | 44.2% |
| Short % of float | 7.8% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).